2025-2031 Global Genetic Disease Diagnostic Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Medical Care > 2025-2031 Global Genetic Disease Diagnostic Industry Research & Trends Analysis Report

2025-2031 Global Genetic Disease Diagnostic Industry Research & Trends Analysis Report

Publication Date: 2025-11-19
Report Id: 2807102
Industry: Medical Care
Report Page: 122
Chart: 125

PDF Download

Publication Date: 2025-11-19
Report Id: 2807102
Industry: Medical Care
Report Page: 122
Chart: 125

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of Genetic Disease Diagnostic
1.2 Global Genetic Disease Diagnostic Market Size and Forecast
1.3 China Genetic Disease Diagnostic Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Genetic Disease Diagnostic Share in Global Market, 2020-2031
1.4.2 Genetic Disease Diagnostic Market Size: China VS Global, 2020-2031
1.5 Genetic Disease Diagnostic Market Dynamics
1.5.1 Genetic Disease Diagnostic Market Drivers
1.5.2 Genetic Disease Diagnostic Market Restraints
1.5.3 Genetic Disease Diagnostic Industry Trends
1.5.4 Genetic Disease Diagnostic Industry Policy

2 Competitive Landscape by Company
2.1 Global Genetic Disease Diagnostic Revenue by Company, 2020-2025
2.2 Global Genetic Disease Diagnostic Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Genetic Disease Diagnostic Concentration Ratio
2.4 Global Genetic Disease Diagnostic Mergers & Acquisitions, Expansion Plans
2.5 Global Genetic Disease Diagnostic Manufacturers Product Type
2.6 Global Geographic Distribution of Genetic Disease Diagnostic Companies

3 China Competitive Situation by Company
3.1 China Genetic Disease Diagnostic Revenue by Company, 2020-2025
3.2 China Genetic Disease Diagnostic Genetic Disease Diagnostic Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Genetic Disease Diagnostic Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 Genetic Disease Diagnostic Industry Chain
4.2 Genetic Disease Diagnostic Upstream Analysis
4.3 Genetic Disease Diagnostic Midstream Analysis
4.4 Genetic Disease Diagnostic Downstream Analysis

5 Sights by Type
5.1 Genetic Disease Diagnostic Classification
5.1.1 Prenatal Diagnosis
5.1.2 Screening for Single Gene Genetic Disease
5.1.3 Preimplantation Genetic Testing
5.1.4 Others
5.2 by Type, Global Genetic Disease Diagnostic Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Genetic Disease Diagnostic Market Size, 2020-2031

6 Sights by Application
6.1 Genetic Disease Diagnostic Segment by Application
6.1.1 Hospital
6.1.2 Medical Laboratory
6.1.3 Others
6.2 by Application, Global Genetic Disease Diagnostic Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Genetic Disease Diagnostic Market Size, 2020-2031

7 Sights by Region
7.1 By Region, Global Genetic Disease Diagnostic Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global Genetic Disease Diagnostic Market Size, 2020-2031
7.3 North America
7.3.1 North America Genetic Disease Diagnostic Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Genetic Disease Diagnostic Market Size Market Share
7.4 Europe
7.4.1 Europe Genetic Disease Diagnostic Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Genetic Disease Diagnostic Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Genetic Disease Diagnostic Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Genetic Disease Diagnostic Market Size Market Share
7.6 South America
7.6.1 South America Genetic Disease Diagnostic Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Genetic Disease Diagnostic Market Size Market Share
7.7 Middle East & Africa

8 Sights by Country Level
8.1 By Country, Global Genetic Disease Diagnostic Market Size & CAGR，2020 VS 2024 VS 2031
8.2 By Country, Global Genetic Disease Diagnostic Market Size, 2020-2031
8.3 United States
8.3.1 United States Genetic Disease Diagnostic Market Size, 2020-2031
8.3.2 By Company, United States Genetic Disease Diagnostic Revenue Market Share, 2024
8.3.3 by Type, United States Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Genetic Disease Diagnostic Market Size, 2020-2031
8.4.2 By Company, Europe Genetic Disease Diagnostic Revenue Market Share, 2024
8.4.3 by Type, Europe Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China Genetic Disease Diagnostic Market Size, 2020-2031
8.5.2 By Company, China Genetic Disease Diagnostic Revenue Market Share, 2024
8.5.3 by Type, China Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Genetic Disease Diagnostic Market Size, 2020-2031
8.6.2 By Company, Japan Genetic Disease Diagnostic Revenue Market Share, 2024
8.6.3 by Type, Japan Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Genetic Disease Diagnostic Market Size, 2020-2031
8.7.2 By Company, South Korea Genetic Disease Diagnostic Revenue Market Share, 2024
8.7.3 by Type, South Korea Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Genetic Disease Diagnostic Market Size, 2020-2031
8.8.2 By Company, Southeast Asia Genetic Disease Diagnostic Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India Genetic Disease Diagnostic Market Size, 2020-2031
8.9.2 By Company, India Genetic Disease Diagnostic Revenue Market Share, 2024
8.9.3 by Type, India Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Genetic Disease Diagnostic Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa Genetic Disease Diagnostic Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa Genetic Disease Diagnostic Revenue Market Share, 2024 VS 2031

9 Company Profile
9.1 Abbott
9.1.1 Abbott Company Information, Head Office, Market Area, and Industry Position
9.1.2 Abbott Company Profile and Main Business
9.1.3 Abbott Genetic Disease Diagnostic Models, Specifications, and Application
9.1.4 Abbott Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.1.5 Abbott Recent Developments
9.2 PerkinElmer
9.2.1 PerkinElmer Company Information, Head Office, Market Area, and Industry Position
9.2.2 PerkinElmer Company Profile and Main Business
9.2.3 PerkinElmer Genetic Disease Diagnostic Models, Specifications, and Application
9.2.4 PerkinElmer Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.2.5 PerkinElmer Recent Developments
9.3 Roche Diagnostics
9.3.1 Roche Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.3.2 Roche Diagnostics Company Profile and Main Business
9.3.3 Roche Diagnostics Genetic Disease Diagnostic Models, Specifications, and Application
9.3.4 Roche Diagnostics Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.3.5 Roche Diagnostics Recent Developments
9.4 Bio Rad
9.4.1 Bio Rad Company Information, Head Office, Market Area, and Industry Position
9.4.2 Bio Rad Company Profile and Main Business
9.4.3 Bio Rad Genetic Disease Diagnostic Models, Specifications, and Application
9.4.4 Bio Rad Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.4.5 Bio Rad Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
9.5.2 Thermo Fisher Scientific Company Profile and Main Business
9.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Models, Specifications, and Application
9.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.5.5 Thermo Fisher Scientific Recent Developments
9.6 BGI Group
9.6.1 BGI Group Company Information, Head Office, Market Area, and Industry Position
9.6.2 BGI Group Company Profile and Main Business
9.6.3 BGI Group Genetic Disease Diagnostic Models, Specifications, and Application
9.6.4 BGI Group Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.6.5 BGI Group Recent Developments
9.7 Berry Genomics
9.7.1 Berry Genomics Company Information, Head Office, Market Area, and Industry Position
9.7.2 Berry Genomics Company Profile and Main Business
9.7.3 Berry Genomics Genetic Disease Diagnostic Models, Specifications, and Application
9.7.4 Berry Genomics Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.7.5 Berry Genomics Recent Developments
9.8 Da An Gene Co., Ltd.
9.8.1 Da An Gene Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
9.8.2 Da An Gene Co., Ltd. Company Profile and Main Business
9.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Models, Specifications, and Application
9.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.8.5 Da An Gene Co., Ltd. Recent Developments
9.9 Illumina
9.9.1 Illumina Company Information, Head Office, Market Area, and Industry Position
9.9.2 Illumina Company Profile and Main Business
9.9.3 Illumina Genetic Disease Diagnostic Models, Specifications, and Application
9.9.4 Illumina Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.9.5 Illumina Recent Developments
9.10 CapitalBio Technology
9.10.1 CapitalBio Technology Company Information, Head Office, Market Area, and Industry Position
9.10.2 CapitalBio Technology Company Profile and Main Business
9.10.3 CapitalBio Technology Genetic Disease Diagnostic Models, Specifications, and Application
9.10.4 CapitalBio Technology Genetic Disease Diagnostic Revenue and Gross Margin, 2020-2025
9.10.5 CapitalBio Technology Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Genetic Disease Diagnostic should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of %for the period of 2025-2031.

Hereditary diseases are those caused by changes in genetic material or controlled by disease-causing genes. Hereditary diseases refer to diseases that are determined wholly or partly by genetic factors, usually congenital or acquired. Be like congenital foolish model, much point to (toe), congenital deafness dumb, hemophilia, these hereditary disease decides to come on completely by genetic factor, and just after be born certain time comes on, want to pass a few years sometimes, more than ten years even ability after decades appears apparent symptom.At present, China has adopted a variety of neonatal disease screening technologies for early diagnosis and treatment of children with genetic diseases without clinical symptoms, effectively reducing the disability rate and mortality rate of children, and greatly reducing the serious harm caused by birth defects to families and society. In recent years, with the rapid development of molecular biology and genomics, genetic testing technology has become the gold standard when it comes to most of the hereditary disease diagnosis, especially in the biochemical or enzymatic method can"t make a diagnosis and test results under the condition of not clear, genetic testing is an important means of diagnosis, but in the field of neonatal hereditary disease screening, genetic testing technology is not yet ripe for applications, Gene screening for neonatal deafness has been reported in China.

In China markets, the core manufacturers of genetic disease diagnostic includes BGI Group, Berry Genomics etc and the top 5 companies hold a share over 40%.

This report aims to provide a comprehensive study of the global market for Genetic Disease Diagnostic. Report Highlights:
(1) Global Genetic Disease Diagnostic market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global Genetic Disease Diagnostic market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China Genetic Disease Diagnostic market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global Genetic Disease Diagnostic segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Genetic Disease Diagnostic segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Genetic Disease Diagnostic industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others

Market segment by Application, can be divided into
Hospital
Medical Laboratory
Others

Market segment by players, this report covers
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology